#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Carriage of in the Upper Respiratory Tract of Symptomatic and Asymptomatic Children: An Observational Study


Background:
Mycoplasma pneumoniae is thought to be a common cause of respiratory tract infections (RTIs) in children. The diagnosis of M. pneumoniae RTIs currently relies on serological methods and/or the detection of bacterial DNA in the upper respiratory tract (URT). It is conceivable, however, that these diagnostic methods also yield positive results if M. pneumoniae is carried asymptomatically in the URT. Positive results from these tests may therefore not always be indicative of a symptomatic infection. The existence of asymptomatic carriage of M. pneumoniae has not been established. We hypothesized that asymptomatic carriage in children exists and investigated whether colonization and symptomatic infection could be differentiated by current diagnostic methods.

Methods and Findings:
This study was conducted at the Erasmus MC–Sophia Children's Hospital and the after-hours General Practitioners Cooperative in Rotterdam, The Netherlands. Asymptomatic children (n = 405) and children with RTI symptoms (n = 321) aged 3 mo to 16 y were enrolled in a cross-sectional study from July 1, 2008, to November 30, 2011. Clinical data, pharyngeal and nasopharyngeal specimens, and serum samples were collected. The primary objective was to differentiate between colonization and symptomatic infection with M. pneumoniae by current diagnostic methods, especially real-time PCR. M. pneumoniae DNA was detected in 21.2% (95% CI 17.2%–25.2%) of the asymptomatic children and in 16.2% (95% CI 12.2%–20.2%) of the symptomatic children (p = 0.11). Neither serology nor quantitative PCR nor culture differentiated asymptomatic carriage from infection. A total of 202 children were tested for the presence of other bacterial and viral pathogens. Two or more pathogens were found in 56% (63/112) of the asymptomatic children and in 55.5% (50/90) of the symptomatic children. Finally, longitudinal sampling showed persistence of M. pneumoniae in the URT for up to 4 mo. Fifteen of the 21 asymptomatic children with M. pneumoniae and 19 of the 22 symptomatic children with M. pneumoniae in this longitudinal follow-up tested negative after 1 mo.

Conclusions:
Although our study has limitations, such as a single study site and limited sample size, our data indicate that the presence of M. pneumoniae in the URT is common in asymptomatic children. The current diagnostic tests for M. pneumoniae are unable to differentiate between asymptomatic carriage and symptomatic infection.

Please see later in the article for the Editors' Summary


Vyšlo v časopise: Carriage of in the Upper Respiratory Tract of Symptomatic and Asymptomatic Children: An Observational Study. PLoS Med 10(5): e32767. doi:10.1371/journal.pmed.1001444
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001444

Souhrn

Background:
Mycoplasma pneumoniae is thought to be a common cause of respiratory tract infections (RTIs) in children. The diagnosis of M. pneumoniae RTIs currently relies on serological methods and/or the detection of bacterial DNA in the upper respiratory tract (URT). It is conceivable, however, that these diagnostic methods also yield positive results if M. pneumoniae is carried asymptomatically in the URT. Positive results from these tests may therefore not always be indicative of a symptomatic infection. The existence of asymptomatic carriage of M. pneumoniae has not been established. We hypothesized that asymptomatic carriage in children exists and investigated whether colonization and symptomatic infection could be differentiated by current diagnostic methods.

Methods and Findings:
This study was conducted at the Erasmus MC–Sophia Children's Hospital and the after-hours General Practitioners Cooperative in Rotterdam, The Netherlands. Asymptomatic children (n = 405) and children with RTI symptoms (n = 321) aged 3 mo to 16 y were enrolled in a cross-sectional study from July 1, 2008, to November 30, 2011. Clinical data, pharyngeal and nasopharyngeal specimens, and serum samples were collected. The primary objective was to differentiate between colonization and symptomatic infection with M. pneumoniae by current diagnostic methods, especially real-time PCR. M. pneumoniae DNA was detected in 21.2% (95% CI 17.2%–25.2%) of the asymptomatic children and in 16.2% (95% CI 12.2%–20.2%) of the symptomatic children (p = 0.11). Neither serology nor quantitative PCR nor culture differentiated asymptomatic carriage from infection. A total of 202 children were tested for the presence of other bacterial and viral pathogens. Two or more pathogens were found in 56% (63/112) of the asymptomatic children and in 55.5% (50/90) of the symptomatic children. Finally, longitudinal sampling showed persistence of M. pneumoniae in the URT for up to 4 mo. Fifteen of the 21 asymptomatic children with M. pneumoniae and 19 of the 22 symptomatic children with M. pneumoniae in this longitudinal follow-up tested negative after 1 mo.

Conclusions:
Although our study has limitations, such as a single study site and limited sample size, our data indicate that the presence of M. pneumoniae in the URT is common in asymptomatic children. The current diagnostic tests for M. pneumoniae are unable to differentiate between asymptomatic carriage and symptomatic infection.

Please see later in the article for the Editors' Summary


Zdroje

1. BradleyJS, ByingtonCL, ShahSS, AlversonB, CarterER, et al. (2011) The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis 53: e25–e76.

2. HarrisM, ClarkJ, CooteN, FletcherP, HarndenA, et al. (2011) British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax 66(Suppl 2): ii1–ii23.

3. NilssonAC, BjorkmanP, PerssonK (2008) Polymerase chain reaction is superior to serology for the diagnosis of acute Mycoplasma pneumoniae infection and reveals a high rate of persistent infection. BMC Microbiol 8: 93.

4. WaitesKB, TalkingtonDF (2004) Mycoplasma pneumoniae and its role as a human pathogen. Clin Microbiol Rev 17: 697–728.

5. UrsiD, IevenM, NoordhoekGT, RitzlerM, ZandlevenH, et al. (2003) An interlaboratory comparison for the detection of Mycoplasma pneumoniae in respiratory samples by the polymerase chain reaction. J Microbiol Methods 53: 289–294.

6. LiuY, YeX, ZhangH, XuX, LiW, et al. (2010) Characterization of macrolide resistance in Mycoplasma pneumoniae isolated from children in Shanghai, China. Diagn Microbiol Infect Dis 67: 355–358.

7. CaoB, ZhaoCJ, YinYD, ZhaoF, SongSF, et al. (2010) High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China. Clin Infect Dis 51: 189–194.

8. Dorigo-ZetsmaJW, WilbrinkB, van der NatH, BarteldsAI, HeijnenML, et al. (2001) Results of molecular detection of Mycoplasma pneumoniae among patients with acute respiratory infection and in their household contacts reveals children as human reservoirs. J Infect Dis 183: 675–678.

9. FoyHM, GraystonJT, KennyGE, AlexanderER, McMahanR (1966) Epidemiology of Mycoplasma pneumoniae infection in families. JAMA 197: 859–866.

10. FoyHM, KennyGE, McMahanR, KaiserG, GraystonJT (1971) Mycoplasma pneumoniae in the community. Am J Epidemiol 93: 55–67.

11. GnarpeJ, LundbackA, SundelofB, GnarpeH (1992) Prevalence of Mycoplasma pneumoniae in subjectively healthy individuals. Scand J Infect Dis 24: 161–164.

12. HydeTB, GilbertM, SchwartzSB, ZellER, WattJP, et al. (2001) Azithromycin prophylaxis during a hospital outbreak of Mycoplasma pneumoniae pneumonia. J Infect Dis 183: 907–912.

13. FeikinDR, NjengaMK, BigogoG, AuraB, AolG, et al. (2012) Etiology and incidence of viral and bacterial acute respiratory illness among older children and adults in rural western Kenya, 2007–2010. PLoS ONE 7: e43656 doi:10.1371/journal.pone.0043656.

14. GoldwaterPN, MartinAJ, RyanB, MorrisS, ThompsonJ, et al. (1991) A survey of nosocomial respiratory viral infections in a children's hospital: occult respiratory infection in patients admitted during an epidemic season. Infect Control Hosp Epidemiol 12: 231–238.

15. WenzelRP, CravenRB, DaviesJA, HendleyJO, HamoryBH, et al. (1977) Protective efficacy of an inactivated Mycoplasma pneumoniae vaccine. J Infect Dis 136(Suppl): S204–S207.

16. SpuesensEB, HoogenboezemT, SluijterM, HartwigNG, van RossumAM, et al. (2010) Macrolide resistance determination and molecular typing of Mycoplasma pneumoniae by pyrosequencing. J Microbiol Methods 82: 214–222.

17. SluijterM, HoogenboezemT, HartwigNG, VinkC (2008) The Mycoplasma pneumoniae MPN229 gene encodes a protein that selectively binds single-stranded DNA and stimulates Recombinase A-mediated DNA strand exchange. BMC Microbiol 8: 167.

18. Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, et al.. (2011) Manual of clinical microbiology, 10th ed. Washington (District of Columbia): ASM Press.

19. HoekRA, PaatsMS, PasSD, BakkerM, HoogstedenHC, et al. (2013) Incidence of viral respiratory pathogens causing exacerbations in adult cystic fibrosis patients. Scand J Infect Dis 45: 65–69.

20. BogaertD, van BelkumA, SluijterM, LuijendijkA, de GrootR, et al. (2004) Colonisation by Streptococcus pneumoniae and Staphylococcus aureus in healthy children. Lancet 363: 1871–1872.

21. RasmussenJN, VoldstedlundM, AndersenRL, Ellermann-EriksenS, JensenTG, et al. (2010) Increased incidence of Mycoplasma pneumoniae infections detected by laboratory-based surveillance in Denmark in 2010. Euro Surveill 15: 19708.

22. MaltezouHC, La-ScolaB, AstraH, ConstantopoulouI, VlahouV, et al. (2004) Mycoplasma pneumoniae and Legionella pneumophila in community-acquired lower respiratory tract infections among hospitalized children: diagnosis by real time PCR. Scand J Infect Dis 36: 639–642.

23. MichelowIC, OlsenK, LozanoJ, DuffyLB, McCrackenGH, et al. (2004) Diagnostic utility and clinical significance of naso- and oropharyngeal samples used in a PCR assay to diagnose Mycoplasma pneumoniae infection in children with community-acquired pneumonia. J Clin Microbiol 42: 3339–3341.

24. ChanockRM, RifkindD, KravetzHM, KinghtV, JohnsonKM (1961) Respiratory disease in volunteers infected with Eaton agent: a preliminary report. Proc Natl Acad Sci U S A 47: 887–890.

25. BogaertD, De GrootR, HermansPW (2004) Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis 4: 144–154.

26. FoyHM (1993) Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin Infect Dis 17(Suppl 1): S37–S46.

27. PalmaSC, MartinezTM, SalinasSM, RojasGP (2005) [Asymptomatic pharyngeal carriage of Mycoplasma pneumoniae in Chilean children.]. Rev Chilena Infectol 22: 247–250.

28. KumarS, WangL, FanJ, KraftA, BoseME, et al. (2008) Detection of 11 common viral and bacterial pathogens causing community-acquired pneumonia or sepsis in asymptomatic patients by using a multiplex reverse transcription-PCR assay with manual (enzyme hybridization) or automated (electronic microarray) detection. J Clin Microbiol 46: 3063–3072.

Štítky
Interné lekárstvo

Článok vyšiel v časopise

PLOS Medicine


2013 Číslo 5
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#